Ral-GTPase interacts with the β1 subunit of Na+/K+-ATPase and is activated upon inhibition of the Na+/K+ pump

被引:5
|
作者
Bhullar, Rajinder P.
Clough, Richard R.
Kanungo, Juddy
Elsaraj, Sherif M.
Grujic, Ognjen
机构
[1] Univ Manitoba, Dept Oral Biol, Winnipeg, MB R3E 0W2, Canada
[2] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0W2, Canada
[3] Univ Manitoba, Dept Oral Biol, Winnipeg, MB R3E 0W2, Canada
关键词
Ral; GTPases; Na+/K+-ATPase; ouabain; angiotensin II; A7r5; cells;
D O I
10.1139/Y07-027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Na+/K+-ATPase functions as both an ion pump and a signal transducer. Cardiac glycosides partially inhibit Na+/K+-ATPase, causing activation of multiple interrelated growth pathways via the Na+/K+-ATPase/c-Src/epidermal growth factor receptor complex. Such pathways include Ras/MEK/ERK and Ral/RalGDS cascades, which can lead to cardiac hypertrophy. In search of novel Ral-GTPase binding proteins, we used RalB as the bait to screen a human testes cDNA expression library using the yeast 2-hybrid system. The results demonstrated that I of the RalB interacting clones represented the C-terminal region of the beta 1 subunit of Na+/K+-ATPase. Further analysis using the yeast 2-hybrid system and full-length beta 1 subunit of Na+/K+-ATPase confirmed the interaction with RalA and RalB. In vitro binding and pull-down assays demonstrated that the beta 1 subunit of Na+/K+-ATPase interacts directly with RalA and RalB. Ral-GTP pull-down assays demonstrated that short-term ouabain treatment of A7r5 cells, a rat aorta smooth muscle cell line, caused activation of Ral GTPase. Maximal activation was observed 10 min after ouabain treatment. Ouabain-mediated Ral activation was inhibited upon the stimulation of Na+/K+-ATPase activity by Ang II. We propose that Ral GTPase is involved in the signal transducing function of Na+/K+-ATPase and provides a possible molecular mechanism connecting Ral to cardiac hypertrophy during diseased conditions.
引用
收藏
页码:444 / 454
页数:11
相关论文
共 50 条
  • [21] Salt, Na+,K+-ATPase and hypertension
    Jaitovich, Ariel
    Bertorello, Alejandro M.
    LIFE SCIENCES, 2010, 86 (3-4) : 73 - 78
  • [22] Significance of the beta-subunit in the biogenesis of Na+/K+-ATPase
    Ueno, S
    Takeda, K
    Noguchi, S
    Kawamura, M
    BIOSCIENCE REPORTS, 1997, 17 (02) : 173 - 188
  • [23] The Na+, K+-ATPase: more than just a sodium pump
    Scheiner-Bobis, Georgios
    CARDIOVASCULAR RESEARCH, 2011, 89 (01) : 6 - 8
  • [24] EFFECTS OF VANADATE ON OUABAIN BINDING AND INHIBITION OF (NA+ + K+)-ATPASE
    MYERS, TD
    BOERTH, RC
    POST, RL
    BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 558 (01) : 99 - 107
  • [25] Non-preferential fuelling of the Na+/K+-ATPase pump
    Fernandez-Moncada, Ignacio
    Felipe Barros, L.
    BIOCHEMICAL JOURNAL, 2014, 460 : 353 - 361
  • [26] Immunohistochemical Analyses of α1 and α3 Na+/K+-ATPase Subunit Expression in Medulloblastomas
    Sunol, Mariona
    Cusi, Victoria
    Cruz, Ofelia
    Kiss, Robert
    Lefranc, Florence
    ANTICANCER RESEARCH, 2011, 31 (03) : 953 - 958
  • [27] Inhibition of Na+, K+-ATPase activity in rat striatum by guanidinoacetate
    Zugno, AI
    Stefanello, FM
    Streck, EL
    Calcagnotto, T
    Wannmacher, CMD
    Wajner, M
    Wyse, ATS
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2003, 21 (04) : 183 - 189
  • [28] Na+/K+ ATPase Inhibitors in Cancer
    Alevizopoulos, Konstantinos
    Calogeropoulou, Theodora
    Lang, Florian
    Stournaras, Christos
    CURRENT DRUG TARGETS, 2014, 15 (10) : 988 - 1000
  • [29] Effects of ouabain on proliferation of human endothelial cells correlate with Na+,K+-ATPase activity and intracellular ratio of Na+ and K+
    A. M. Tverskoi
    S. V. Sidorenko
    E. A. Klimanova
    O. A. Akimova
    L. V. Smolyaninova
    O. D. Lopina
    S. N. Orlov
    Biochemistry (Moscow), 2016, 81 : 876 - 883
  • [30] Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma
    Zhuang, Liping
    Xu, Litao
    Wang, Peng
    Jiang, Yan
    Yong, Pan
    Zhang, Chenyue
    Zhang, Haibin
    Meng, Zhiqiang
    Yang, Peiying
    ONCOTARGET, 2015, 6 (29) : 28183 - 28193